• News from CROI 2022 – caveats using antiretrovirals as HIV prophylaxis 

      Barreiro, Pablo; Soriano, Vicente (AIDS Reviews, 2022)
      The annual conference on retroviruses and opportunistic infections was held in Denver, CO, last February. Most sessions were attended by virtual attenders, due to restrictions forced by the COVID-19 surge caused by the ...
    • Safety considerations in the management of hepatitis C and HIV co-infection 

      Soriano, Vicente; Moreno-Torres, Víctor; Treviño, Ana; Barreiro, Pablo; de Jesús-Franco, Fernando; Corral, Octavio Jorge; de Mendoza, Carmen (Expert Opinion on Drug Safety, 2023)
      Introduction: Both HCV and HIV are highly prevalent infections with current estimates of 57 and 38 million people infected worldwide, respectively. Oral antivirals can be curative for HCV and rescue HIV patients from disease ...
    • Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain 

      Requena, S.; Caballero, Estrella; Lozano, A. B.; Ríos-Villegas, María; Benito, Rafael; Rojo, Silvia; Cabezas, Teresa; Macià, María; Nieto, María del; Soriano, Vicente ; Mendoza, Carmen de (AIDS, 15/11/2019)
      Background: Whereas HIV-1 has spread globally, HIV-2 is mainly found in West Africa where dual HIV-1/HIV-2 coinfection is nowadays uncommon. Herein, we report the rate, main characteristics, and treatment outcomes of all ...